Efficacy of Henna cream in cutaneous problems induced by cancer therapy

Comparison of the effectiveness of discolored Henna cream with placebo in the treatment of cutaneous problems induced by chemotherapy and radiotherapy in cancer patients

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20160813029327N7

Enrollment

Registered

2018-02-24

Start date

2016-10-22

Completion date

Unknown

Last updated

2018-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skin reaction induced by radiotherapy, Hand and foot syndrom induced by chemotherapy. Acute radiodermatitis, Localized skin eruption due to drugs and medicaments

Interventions

Intervention 1: Intervention group: Patients use the discolored Henna cream on the skin reaction involved erea two times a day for two weeks to one month according to skin reaction severity. Intervent

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patiens having cancer Patients having cutaneous problems induced by chemotherapy or radiotherapy

Exclusion criteria

Exclusion criteria: Patients having skin cancer Patients having skin infections Patients having allergy to herbal products including Henna

Design outcomes

Primary

Measure	Time frame
Skin reaction severity induced by radiotherapy. Timepoint: Befor intervention and at the end of the intervention. Method of measurement: Based on Common Terminology Criteria for Adverse Events and Skindex-16 questionnaire.;Hand and foot syndrom severity. Timepoint: Befor intervention and at the end of the intervention. Method of measurement: Based on Common Terminology Criteria for Adverse Events and Skindex-16 questionnaire.	—

Measure

Time frame

Skin reaction severity induced by radiotherapy. Timepoint: Befor intervention and at the end of the intervention. Method of measurement: Based on Common Terminology Criteria for Adverse Events and Skindex-16 questionnaire.;Hand and foot syndrom severity. Timepoint: Befor intervention and at the end of the intervention. Method of measurement: Based on Common Terminology Criteria for Adverse Events and Skindex-16 questionnaire.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAtefeh Khodabakhshi

Islamic Azad University

Atefe.c72@gmail.com+98 21 2264 0051

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026